TYKERB/TYVERB

lapatinib · GlaxoSmithKline

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TYKERB/TYVERB, covering 2018-06-19 to 2018-06-19. Get the full timeline:

Most recent: Clinical Trial Update: Pilot Study of Patient's Adherence to TYKERB™/TYVERB™ + Capecitabine in Metastatic Breast Cancer